Re: Is this president stuff going to your head BearDownAZ
|
6
|
Resverlogix Corp.
|
Mar 22, 2018 03:08PM
|
Re: AEGIS-II trial
|
5
|
Resverlogix Corp.
|
Mar 22, 2018 08:20PM
|
Apabetalone Treatment of CKD Patientsis Associated with Favorable Kidney Function and Alkaline Phosphatase Profile
|
7
|
Resverlogix Corp.
|
Mar 23, 2018 10:02AM
|
Re: Apabetalone Treatment of CKD Patientsis Associated with Favorable Kidney Function and Alkaline Phosphatase Profile
|
4
|
Resverlogix Corp.
|
Mar 23, 2018 10:11AM
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 24, 2018 07:24AM
|
Bioasis Announces Key Strategic Appointment to its Senior Leadership Team with Addition of Caroline Hill, Ph.D., Leading R & D Operations
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 26, 2018 10:44AM
|
Re: Caroline Hill, Ph.D. Appointed SVP, Head of R&D Operations at Bioasis
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 26, 2018 04:51PM
|
MD&A March 26, 2018
|
8
|
Zenith Epigenetics
|
Mar 27, 2018 06:35PM
|
Endpoint News BET Inhibitors
|
6
|
Zenith Epigenetics
|
Mar 27, 2018 08:21PM
|
Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
|
4
|
Resverlogix Corp.
|
Mar 28, 2018 07:29AM
|
Re: Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
|
5
|
Resverlogix Corp.
|
Mar 28, 2018 07:34AM
|
Re: Is the message really getting out there
|
9
|
Resverlogix Corp.
|
Mar 28, 2018 01:28PM
|
Reports of exempt distribution on SEDAR
|
4
|
Resverlogix Corp.
|
Mar 28, 2018 11:09PM
|
Re: Reports of exempt distribution on SEDAR
|
6
|
Resverlogix Corp.
|
Mar 29, 2018 10:29AM
|
Re: New Organ Discovered
|
3
|
Zenith Epigenetics
|
Mar 29, 2018 06:13PM
|
Epigenetics in CKD & CVD: A potential breakthrough therapy? Epigenetics in CKD & CVD: A potential breakthrough therapy?
|
4
|
Resverlogix Corp.
|
Mar 31, 2018 11:37AM
|
Re: dependent on RVX?
|
4
|
Zenith Epigenetics
|
Apr 03, 2018 11:30AM
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 03, 2018 03:46PM
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 03, 2018 03:51PM
|
Re: Que sera sera....
|
5
|
Resverlogix Corp.
|
Apr 03, 2018 04:57PM
|